Comparative Effectiveness Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications

BACKGROUND: Recombinant Factor VIIa (rFVIIa), a hemostatic agent approved for hemophilia, is increasingly used for off-label indications. PURPOSE: To evaluate benefits and harms of rFVIIa use for five off-label, in-hospital indications: intracranial hemorrhage, cardiac surgery, trauma, liver transpl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yank, Veronica, Tuohy, C. Vaughan, Logan, Aaron C., Bravata, Dena M., Staudenmayer, Kristan, Eisenhut, Robin, Sundaram, Vandana, McMahon, Donal, Olkin, Ingram, McDonald, Kathryn M., Owens, Douglas K., Stafford, Randall S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102260/
https://ncbi.nlm.nih.gov/pubmed/21502651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/0003-4819-154-8-201104190-00004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares